Squarepoint Ops LLC Emergent Bio Solutions Inc. Transaction History

Squarepoint Ops LLC

  • $93.7 Billion
  • Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 24,440 shares of EBS stock, worth $250,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,440
Previous 227,936 89.28%
Holding current value
$250,998
Previous $1.11 Million 86.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 27, 2025
SELL
$4.26 - $6.94 $866,892 - $1.41 Million
-203,496 Reduced 89.28%
24,440 $155,000
Q2 2025

Aug 14, 2025
SELL
$4.26 - $6.94 $866,892 - $1.41 Million
-203,496 Reduced 89.28%
24,440 $155,000
Q1 2025

Aug 27, 2025
BUY
$4.66 - $11.66 $948,291 - $2.37 Million
203,496 Added 832.64%
227,936 $1.11 Million
Q1 2025

May 15, 2025
BUY
$4.66 - $11.66 $842,145 - $2.11 Million
180,718 Added 382.73%
227,936 $1.11 Million
Q4 2024

Feb 14, 2025
SELL
$7.72 - $11.97 $1.26 Million - $1.95 Million
-163,227 Reduced 77.56%
47,218 $451,000
Q3 2024

Nov 14, 2024
SELL
$5.72 - $14.77 $117,654 - $303,804
-20,569 Reduced 8.9%
210,445 $1.76 Million
Q2 2024

Aug 14, 2024
BUY
$1.86 - $6.98 $429,686 - $1.61 Million
231,014 New
231,014 $1.58 Million
Q4 2023

Feb 14, 2024
BUY
$1.82 - $3.16 $55,289 - $95,997
30,379 Added 62.25%
79,181 $190,000
Q2 2023

Aug 14, 2023
BUY
$7.35 - $13.21 $162,221 - $291,557
22,071 Added 82.57%
48,802 $358,000
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $127,148 - $265,885
16,322 Added 156.81%
26,731 $276,000
Q4 2022

Feb 14, 2023
SELL
$11.0 - $21.45 $41,481 - $80,887
-3,771 Reduced 26.59%
10,409 $122,000
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $284,876 - $507,643
14,180 New
14,180 $298,000
Q1 2022

May 16, 2022
SELL
$36.48 - $52.22 $242,993 - $347,837
-6,661 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $99 - $165
3 Added 0.05%
6,661 $290,000
Q3 2021

Nov 15, 2021
BUY
$50.07 - $66.05 $333,366 - $439,760
6,658 New
6,658 $333,000
Q2 2021

Aug 16, 2021
SELL
$56.61 - $80.46 $1.24 Million - $1.77 Million
-21,958 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$86.23 - $125.19 $1.89 Million - $2.75 Million
21,958 New
21,958 $2.04 Million
Q4 2020

Feb 16, 2021
SELL
$79.17 - $111.47 $1.25 Million - $1.76 Million
-15,785 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$81.91 - $134.94 $2.32 Million - $3.83 Million
-28,355 Reduced 64.24%
15,785 $1.63 Million
Q2 2020

Aug 14, 2020
BUY
$54.33 - $89.52 $661,576 - $1.09 Million
12,177 Added 38.1%
44,140 $3.49 Million
Q1 2020

May 15, 2020
BUY
$49.34 - $68.76 $1.06 Million - $1.47 Million
21,418 Added 203.11%
31,963 $1.85 Million
Q4 2019

Feb 14, 2020
BUY
$51.21 - $59.06 $203,508 - $234,704
3,974 Added 60.48%
10,545 $569,000
Q3 2019

Nov 14, 2019
SELL
$40.6 - $57.2 $1.37 Million - $1.93 Million
-33,741 Reduced 83.7%
6,571 $344,000
Q2 2019

Aug 14, 2019
BUY
$39.92 - $53.86 $1.61 Million - $2.17 Million
40,312 New
40,312 $1.95 Million
Q1 2019

May 15, 2019
SELL
$48.23 - $66.16 $277,901 - $381,213
-5,762 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$55.63 - $73.24 $207,333 - $272,965
-3,727 Reduced 39.28%
5,762 $342,000
Q3 2018

Nov 14, 2018
BUY
$52.05 - $66.51 $493,902 - $631,113
9,489 New
9,489 $625,000
Q1 2018

May 15, 2018
SELL
$44.44 - $54.39 $1.33 Million - $1.63 Million
-29,928 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$37.77 - $47.75 $172,155 - $217,644
4,558 Added 17.97%
29,928 $1.39 Million
Q3 2017

Nov 14, 2017
BUY
$34.14 - $40.45 $866,131 - $1.03 Million
25,370
25,370 $1.03 Million

Others Institutions Holding EBS

# of Institutions
189
Shares Held
39.7M
Call Options Held
390K
Put Options Held
157K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $512M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email